Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Brown Forman (BF-B) Cash & Equivalents (2016 - 2026)

Brown Forman (BF-B) has disclosed Cash & Equivalents for 16 consecutive years, with $589.0 million as the latest value for Q1 2024.

  • On a quarterly basis, Cash & Equivalents rose 37.62% to $589.0 million in Q1 2024 year-over-year; TTM through Jan 2024 was $589.0 million, a 37.62% increase, with the full-year FY2023 number at $374.0 million, down 56.91% from a year prior.
  • Cash & Equivalents was $589.0 million for Q1 2024 at Brown Forman, up from $373.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.2 billion in Q3 2021 to a low of $276.0 million in Q1 2020.
  • A 5-year average of $775.3 million and a median of $868.0 million in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 310.21% in 2020, then tumbled 65.69% in 2023.
  • Brown Forman's Cash & Equivalents stood at $964.0 million in 2020, then rose by 11.31% to $1.1 billion in 2021, then rose by 1.3% to $1.1 billion in 2022, then crashed by 65.69% to $373.0 million in 2023, then surged by 57.91% to $589.0 million in 2024.
  • Per Business Quant, the three most recent readings for BF-B's Cash & Equivalents are $589.0 million (Q1 2024), $373.0 million (Q4 2023), and $426.0 million (Q3 2023).